Informations générales (source: ClinicalTrials.gov)

NCT03132116 En recrutement
Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis: A Randomized Controlled Study (BIGG)
Interventional
  • Maladie des griffes du chat
  • Lymphadénite
Phase 3
University Hospital, Toulouse (Voir sur ClinicalTrials)
mai 2017
décembre 2025
28 août 2024
To compare effect of intra-nodal injection of gentamicin versus placebo on the outcome at 28 days of suppurated cat scratch disease's (CSD) lymphadenitis treated by oral azithromycin.
 Voir le détail

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Amiens-Picardie Hospital - Amiens - France Jean-Luc SCHMIT, MD En recrutement Contact (sur clinicalTrials)
Angers Hospital - Angers - France Vincent DUBEE, MD En recrutement Contact (sur clinicalTrials)
Auch Hospital - Auch - France Sophie ARISTA, MD En recrutement Contact (sur clinicalTrials)
Castres Hospital - Castres - France Florence-Sarah KHATIBI, MD En recrutement Contact (sur clinicalTrials)
Hospices Civils Lyon - Lyon - France Florence ADER, MD En recrutement Contact (sur clinicalTrials)
Limoges University Hospital - Limoges - France Pierre WEINBRECK, MD En recrutement Contact (sur clinicalTrials)
Montpellier University Hospital - Montpellier - France David MORQUIN, MD En recrutement Contact (sur clinicalTrials)
Perpignan Hospital - Perpignan - France Léa COLOMBAIN, MD En recrutement Contact (sur clinicalTrials)
Saint-Brieuc Hospital - Saint-Brieuc - France Rodolphe BUZELE, MD En recrutement Contact (sur clinicalTrials)
Saint-Nazaire Hospital - Saint-Nazaire - France Julia BROCHARD, MD En recrutement Contact (sur clinicalTrials)
Tarbes Hospital - Tarbes - France Florian BUSATO, MD En recrutement Contact (sur clinicalTrials)
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Albi Hospital - Albi - France Marie-Anne LAFFONT, MD En recrutement Contact (sur clinicalTrials)
Bordeaux University Hospital - Bordeaux - France Michel DUPON, MD En recrutement Contact (sur clinicalTrials)
Cahors Hospital - Cahors - France Stéphane SIRE, MD En recrutement Contact (sur clinicalTrials)
Microbiology Laboratory - 31059 - Toulouse - France Guillaume MARTIN-BLONDEL, MD En recrutement Contact (sur clinicalTrials)
Montauban Hospital - Montauban - France Marc DELAVAISSIERE, MD En recrutement Contact (sur clinicalTrials)
Nîmes University Hospital - Nîmes - France Catherine LECHICHE, MD En recrutement Contact (sur clinicalTrials)
Pau Hospital - Pau - France Valérie GABORIEAU, MD En recrutement Contact (sur clinicalTrials)
Rennes Hospital - Rennes - France Matthieu REVEST, MD En recrutement Contact (sur clinicalTrials)
Rodez Hospital - Rodez - France Bruno GUERIN, MD En recrutement Contact (sur clinicalTrials)
Vendée Hospital - La Roche-sur-Yon - France Thomas GUIMARD, MD En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Informed consent

- Suppurated CSD's adenitis:

- Suppurated form of adenitis confirmed by echography

- Serology positive for Immunoglobulin G and/or Immunoglobulin M against B.
henselae



- Suppurated adenitis non related to CSD

- Non-suppurated CSD's adenitis

- Suppurated CSD's adenitis already fistulized

- Suspected visceral B. henselae infection (neurologic or ophthalmic symptoms,
hepato-splenic or valvular involvement confirmed by echography)

- Immunodepression (except diabetes)

- Pregnancy

- Contraindication to pus aspiration from lymphadenitis (history of bleeding or
patient taking curative anticoagulation therapy or platelet count < 50.000/mm3)

- Contraindication to azithromycin (history of QT interval prolongation, history of
liver toxicity of hypersensitivity to macrolides or treatment with ergotamine,
dihydroergotamine, bepridil, cisapride, pimozide, mizolastine or colchicine) or to
aminoglycosides (myasthenia, history of hypersensitivity to aminoglycosides).